Akebia Therapeutics, Inc. (AKBA) has a market capitalization of $417.89M and trades at $1.56. The 52-week range is 1.14-4.079.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -75, Earnings Per Share (EPS) of $-0.02, annual revenue of $236.2M.
The stock has a beta of 0.37, operates in the Healthcare sector.
